When grief makes you sick: Bereavement induced systemic inflammation is a question of genotype

Brain, Behavior, and Immunity

Volumn 26, Issue 7, 2012, Pages 1066-1071

  Schultze Florey, Christian R ^a,b   Martínez Maza, Otoniel ^c   Magpantay, Larry ^c   Breen, Elizabeth Crabb ^a   Irwin, Michael R ^a   Gündel, Harald ^d   O'Connor, Mary Frances ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e University of Arizona   (United States)

Author keywords

Aging; Bereavement; Cytokines; Gene; Gene by environment; Grief; IL 1; IL 6, TNF a; Inflammation

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BEREAVEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL STRESS; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRIEF; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; WIDOW;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; DEMOGRAPHY; DNA; DNA PRIMERS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; GRIEF; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1 TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865623134     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.06.009     Document Type: Article

References (37)

1. Arend W.P., Malyak M., Guthridge C.J., Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998, 16:27-55.
2. Boyle P.J., Feng Z., Raab G.M., 2011. Does widowhood increase mortality risk?: testing for selection effects by comparing causes of spousal death. Epidemiology (Cambridge, Mass.) 22, 1-5.
3. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., Lowe G.D.O., Humphries S.E. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1458-1463.
4. Buckley T., Mihailidou A.S., Bartrop R., McKinley S., Ward C., Morel-Kopp M.-C., Spinaze M., Tofler G.H. Haemodynamic changes during early bereavement: potential contribution to increased cardiovascular risk. Heart Lung Circ. 2011, 20:91-98.
5. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
6. Cole S.W., Arevalo J.M.G., Manu K., Telzer E.H., Kiang L., Bower J.E., Irwin M.R., Fuligni A.J. Antagonistic pleiotropy at the human IL6 promoter confers genetic resilience to the pro-inflammatory effects of adverse social conditions in adolescence. Dev. Psychol. 2011, 47:1173-1180.
7. Cole S.W., Arevalo J.M.G., Takahashi R., Sloan E.K., Lutgendorf S.K., Sood A.K., Sheridan J.F., Seeman T.E. Computational identification of gene-social environment interaction at the human IL6 locus. Proc. Natl. Acad. Sci. USA 2010, 107:5681-5686.
8. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY. Acad. Sci. 2001, 933:222-234.
9. Diez-Ruiz A., Tilz G.P., Zangerle R., Baier-Bitterlich G., Wachter H., Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 1995, 54:1-8.
10. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
11. Ferrari S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 2003, 88:255-259.
12. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
13. di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum. Mol. Genet. 1992, 1:450.
14. Gu W., Zeng L., Zhou J., Jiang D.-P., Zhang L., Du D.-Y., Hu P., Chen K., Liu Q., Wang Z.-G., Jiang J.-X. Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Med. 2010, 36:1261-1265.
15. Hall S.K., Perregaux D.G., Gabel C.A., Woodworth T., Durham L.K., Huizinga T.W.F., Breedveld F.C., Seymour A.B. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004, 50:1976-1983.
16. Hobson C.J., Delunas L. National norms and life-event frequencies for the revised social readjustment rating scale. Int. J. Stress Manage. 2001, 8:299-314.
17. Hwang I.-R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
18. Irwin M.R., Cole S.W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 2011, 11:625-632.
19. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 2003, 100:9090-9095.
20. Kroeger K.M., Steer J.H., Joyce D.A., Abraham L.J. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000, 12:110-119.
21. Martikainen P., Valkonen T. Mortality after the death of a spouse: rates and causes of death in a large Finnish cohort. Am. J. Public Health 1996, 86:1087.
22. McDade T.W., Hawkley L.C., Cacioppo J.T. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom. Med. 2006, 68:376-381.
23. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
24. Mira J.P., Cariou A., Grall F., Delclaux C., Losser M.R., Heshmati F., Cheval C., Monchi M., Teboul J.L., Riché F., Leleu G., Arbibe L., Mignon A., Delpech M., Dhainaut J.F. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999, 282:561-568.
25. Olomolaiye O., Wood N., Bidwell J. A novel NlaIII polymorphism in the human IL-6 promoter. Eur. J. Immunogenet. 1998, 25:267.
26. O'Connor M.-F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
27. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 1992, 22:396-402.
28. Prigerson H.G., Maciejewski P.K., Reynolds C.F., Bierhals A.J., Newsom J.T., Fasiczka A., Frank E., Doman J., Miller M.D. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res. 1995, 59:65-79.
29. Prigerson H.G., Horowitz M.J., Jacobs S.C., Parkes C.M., Aslan M., Goodkin K., Raphael B., Marwit S.J., Wortman C., Neimeyer R.A., Bonanno G.A., Block S.D., Kissane D., Boelen P.A., Maercker A., Litz B.T., Johnson J.G., First M.B., Maciejewski P.K. Prolonged grief disorder: psychometric validation of criteria proposed for DSM-V and ICD-11. PLoS Med. 2009, 6:e1000121.
30. Santić Z., Lukić A., Sesar D., Milicević S., Ilakovac V. Long-term follow-up of blood pressure in family members of soldiers killed during the war in Bosnia and Herzegovina. Croat. Med. J. 2006, 47:416-423.
31. Schuld A., Mullington J., Hermann D., Hinze-Selch D., Fenzel T., Holsboer F., Pollmacher T. Effects of granulocyte colony-stimulating factor on night sleep in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999, 276:R1149.
32. Shear M.K., Frank E., Houck P.R., Reynolds C.F. Treatment of complicated grief: a randomized controlled trial. JAMA 2005, 293:2601-2608.
33. Shear M.K., Simon N.M., Wall M., Zisook S., Neimeyer R., Duan N., Reynolds C.F., Lebowitz B., Sung S., Ghesquiere A., Gorscak B., Clayton P., Ito M., Nakajima S., Konishi T., Melhem N.M., Meert K., Schiff M., O'Connor M.-F., First M.B., Sareen J., Bolton J., Skritskaya N., Mancini A.D., Keshaviah A. Complicated grief and related bereavement issues for DSM-5. Depress. Anxiety 2011, 28:103-117.
34. Spitzer R.L., Williams J.B.W., Gibbons M., First M.D. Structured Clinical Interview of the DSM-IV 1994, American Psychiatric Press, Washington, DC.
35. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 2000, 275:18138-18144.
36. Wilson A.G., di Giovine F.S., Blakemore A.I., Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1992, 1:353.
37. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997, 94:3195-3199.